A complete application in a minute
Tailored resume and cover letter, ready to send.
Sirtex Medical Limited is a global leader in healthcare, with offices in the U.S., Australia, Germany, and Singapore, dedicated to improving patient outcomes. Our mission is to be at the forefront of minimally invasive cancer and embolization therapies, and to partner with physicians to provide innovative products that enhance patient outcomes and simplify treatments. Our flagship product, SIR-Spheres Y-90 resin microspheres, is a targeted radiation therapy for liver cancer. To date, we have delivered over 150K doses across 50+ countries, significantly impacting patients’ lives worldwide. Our success is fueled by a dedication to the medical community, professionalism, collaboration, entrepreneurial spirit, and continuous pursuit of innovation.
At Sirtex, we are committed to creating a great workplace and offer a range of benefits, programs, and services to support our employees, ensuring opportunities to contribute to our success and advance their careers. Join our inclusive community where you can collaborate with talented colleagues, bring your ideas to life, and deliver innovative healthcare solutions to patients.
$156,478.00/yr - $195,597.00/yr
The base salary range for this position is within the stated range. Individual compensation will be based on location, skills, experience, and education. This role is eligible to participate in Sirtex’s incentive programs (target bonus of 15% for this position) and benefit plans, including paid time off, health insurance, and 401k matching.
The Senior Manager, HEOR will lead U.S.-focused health economics and outcomes research strategies and provide strategic support for global HEOR activities across key regions such as the EU and Japan. This role focuses on current portfolio and early/late-stage assets to support market access, pricing, and reimbursement through the generation of high-quality economic evidence and real-world data.
The ideal candidate will have strong expertise in the U.S. payer landscape and evidence expectations (CMS, ICER, commercial payers), combined with experience or familiarity with international HTA processes and reimbursement frameworks (e.g., NICE, HAS, IQWiG, MHLW).
Note: Candidates must be available to work onsite with a hybrid schedule (minimum of 3 days in office and 2 days remote).
U.S. Strategy and Execution (Primary Focus):
Global Support (EU, Japan, and Other Priority Markets):
Cross-Functional Collaboration:
Communication and Dissemination:
Education: Advanced degree (PhD, PharmD, MPH, MS, or equivalent) in Health Economics, Public Health, Epidemiology, Pharmacy, or a related field.
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status, age, or any other characteristic protected under applicable law. Sirtex will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.
Sirtex offers diverse and flexible work arrangements, a culture of respect and collaboration, attractive compensation and benefit packages, opportunities for professional growth, challenging work to improve oncology outcomes, and a commitment to company values, safety, and excellence.